| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 3.278 | 9.262 | 17.584 | 26.820 | 34.961 | 32.822 | 42.933 | 61.802 |
| Total Income - EUR | - | - | 3.278 | 9.262 | 17.584 | 26.820 | 34.961 | 32.822 | 42.933 | 61.802 |
| Total Expenses - EUR | - | - | 136 | 1.864 | 5.294 | 11.894 | 16.441 | 20.824 | 26.259 | 24.620 |
| Gross Profit/Loss - EUR | - | - | 3.141 | 7.398 | 12.290 | 14.927 | 18.519 | 11.999 | 16.674 | 37.183 |
| Net Profit/Loss - EUR | - | - | 3.043 | 7.120 | 11.763 | 14.185 | 17.597 | 11.131 | 16.253 | 35.366 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Daniela Hada Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 29 | 0 | 27.952 | 20.109 | 24.959 | 15.237 | 9.045 | 5.438 |
| Current Assets | - | - | 3.156 | 10.330 | 9.008 | 17.648 | 22.359 | 3.692 | 7.008 | 31.763 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 382 | 1.380 | 522 | 3.357 | 4.380 | 3.117 | 121 | 26.141 |
| Cash | - | - | 2.774 | 8.950 | 8.486 | 14.291 | 17.978 | 575 | 6.886 | 5.622 |
| Shareholders Funds | - | - | 3.087 | 10.150 | 21.716 | 29.978 | 46.910 | 16.414 | 14.280 | 35.414 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 98 | 180 | 15.267 | 7.779 | 408 | 2.515 | 1.773 | 1.787 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Daniela Hada Med S.r.l.